Fisogatinib (BLU-554)

Fisogatinib · CStone Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fisogatinib (BLU-554), covering 2023-02-06 to 2023-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma [Phase 1, Phase 2]